Literature DB >> 24557088

Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.

Jonathan Covault1, Timothy Pond, Richard Feinn, Albert J Arias, Cheryl Oncken, Henry R Kranzler.   

Abstract

RATIONALE: Preclinical studies support the hypothesis that endogenous neuroactive steroids mediate some effects of alcohol.
OBJECTIVES: The aim of this study was to examine the effect of dutasteride inhibition of 5α-reduced neuroactive steroid production on subjective responses to alcohol in adult men.
METHODS: Using a within-subject factorial design, 70 men completed four randomly ordered monthly sessions in which pretreatment with 4 mg dutasteride or placebo was paired with a moderate dose of alcohol (0.8 g/kg) or placebo beverage. The pharmacologic effect of dutasteride was measured by an assay of serum androstanediol glucuronide. Self-reports of alcohol effects were obtained at 40-min intervals following alcohol administration using the Biphasic Alcohol Effects Scale (BAES) and the Alcohol Sensation Scale (SS). We used linear mixed models to examine the effects of dutasteride and alcohol on BAES and SS responses and the interaction of dutasteride with the GABRA2 alcohol dependence-associated polymorphism rs279858. We also examined whether exposure to dutasteride influenced drinking in the weeks following each laboratory session.
RESULTS: A single 4-mg dose of dutasteride produced a 70 % reduction in androstanediol glucuronide. Dutasteride pretreatment reduced alcohol effects on the BAES sedation and SS anesthesia scales. There was no interaction of dutasteride with rs279858. Heavy drinkers had fewer heavy drinking days during the 2 weeks following the dutasteride sessions and fewer total drinks in the first week after dutasteride.
CONCLUSIONS: These results provide evidence that neuroactive steroids mediate some of the sedative effects of alcohol in adult men and that dutasteride may reduce drinking, presumably through its effects on neuroactive steroid concentrations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557088      PMCID: PMC4181572          DOI: 10.1007/s00213-014-3487-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.

Authors:  P O Gisleskog; D Hermann; M Hammarlund-Udenaes; M O Karlsson
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

2.  GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Richard Feinn; Maggie Nellissery; Carlos Hernandez-Avila; Cheryl Oncken; A Leslie Morrow; Henry R Kranzler
Journal:  Neuropsychopharmacology       Date:  2005-06       Impact factor: 7.853

3.  Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Richard Feinn; Rahul T Khisti; A Leslie Morrow; Christine E Marx; Lawrence J Shampine; Henry R Kranzler
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

4.  Behavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux.

Authors:  C A Frye; K R Van Keuren; M S Erskine
Journal:  Behav Brain Res       Date:  1996-09       Impact factor: 3.332

5.  Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.

Authors:  Louis Holdstock; Shannon N Penland; A Leslie Morrow; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

6.  The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.

Authors:  Sigrid Nyberg; Agneta Andersson; Elisabeth Zingmark; Göran Wahlström; Torbjörn Bäckström; Inger Sundström-Poromaa
Journal:  Psychoneuroendocrinology       Date:  2005-10       Impact factor: 4.905

7.  Comparison of finasteride versus flutamide in the treatment of hirsutism.

Authors:  L Falsetti; A Gambera; L Legrenzi; C Iacobello; G Bugari
Journal:  Eur J Endocrinol       Date:  1999-10       Impact factor: 6.664

8.  A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.

Authors:  P O Gisleskog; D Hermann; M Hammarlund-Udenaes; M O Karlsson
Journal:  Clin Pharmacol Ther       Date:  1998-12       Impact factor: 6.875

9.  A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.

Authors:  I L Wong; R S Morris; L Chang; M A Spahn; F Z Stanczyk; R A Lobo
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

10.  Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?

Authors:  Matthew M Ford; Jeffrey D Nickel; Deborah A Finn
Journal:  Alcohol       Date:  2005-08       Impact factor: 2.405

View more
  16 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

2.  Voluntary ethanol consumption reduces GABAergic neuroactive steroid (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) in the amygdala of the cynomolgus monkey.

Authors:  Matthew C Beattie; Antoniette M Maldonado-Devincci; Patrizia Porcu; Todd K O'Buckley; James B Daunais; Kathleen A Grant; A Leslie Morrow
Journal:  Addict Biol       Date:  2015-12-02       Impact factor: 4.280

Review 3.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

4.  GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers.

Authors:  Bao-Zhu Yang; Albert J Arias; Richard Feinn; John H Krystal; Joel Gelernter; Ismene L Petrakis
Journal:  Alcohol Clin Exp Res       Date:  2017-11-13       Impact factor: 3.455

5.  Cellular GABAergic Neuroactive Steroid (3α,5α)-3-Hydroxy-Pregnan-20-One (3α,5α-THP) Immunostaining Levels Are Increased in the Ventral Tegmental Area of Human Alcohol Use Disorder Patients: A Postmortem Study.

Authors:  Ahmet Sait Hasirci; Antoniette M Maldonado-Devincci; Matthew C Beattie; Todd K O'Buckley; A Leslie Morrow
Journal:  Alcohol Clin Exp Res       Date:  2017-01-09       Impact factor: 3.455

Review 6.  Clinical Potential of Neurosteroids for CNS Disorders.

Authors:  Doodipala Samba Reddy; William A Estes
Journal:  Trends Pharmacol Sci       Date:  2016-05-05       Impact factor: 14.819

7.  Molecular Correlates of Topiramate and GRIK1 rs2832407 Genotype in Pluripotent Stem Cell-Derived Neural Cultures.

Authors:  Richard Lieberman; Kevin P Jensen; Kaitlin Clinton; Eric S Levine; Henry R Kranzler; Jonathan Covault
Journal:  Alcohol Clin Exp Res       Date:  2020-08-09       Impact factor: 3.455

Review 8.  Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.

Authors:  P Porcu; A M Barron; C A Frye; A A Walf; S-Y Yang; X-Y He; A L Morrow; G C Panzica; R C Melcangi
Journal:  J Neuroendocrinol       Date:  2016-02       Impact factor: 3.627

Review 9.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

10.  Examining the effects of alcohol on GABAA receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells.

Authors:  Richard Lieberman; Henry R Kranzler; Eric S Levine; Jonathan Covault
Journal:  Alcohol       Date:  2017-08-12       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.